Back to results
US 4,233,316 AGranted
Analgesic potentiation
AssigneeMcNeilab, Inc.
InventorJoseph F. Gardocki
Life of this patent
Estimating the term…
Abstract
A method for producing analgesia by administering a 6-methoxy-.alpha.-methyl-2-naphthaleneacetic acid compound with acetaminophen and compositions therefor.
Claims7
A method for producing analgesia which comprises orally administering to a subject suffering from pain
- (1) as primary antinociceptive agent from about 1.4 to 2.1 mg/kg of body weight of a 6-methoxy-.alpha.-methyl-2-naphthaleneacetic acid compound, said compound selected from (a) 6-methoxy-.alpha.-methyl-2-naphthaleneacetic acid having the formula ##STR2## and (b) the non-toxic therapeutically acceptable salts thereof, and (2) as potentiating agent from about 2.8 to 7.5 mg/kg body weight of acetaminophen.
A method for producing analgesia which comprises orally administering to a subject suffering from pain
- (1) as primary antinociceptive agent from about 85 to 125 milligrams of a 6-methoxy-.alpha.-methyl-2-naphthaleneacetic acid compound, said compound selected from (a) 6-methoxy-.alpha.-methyl-2-naphthaleneacetic acid and (b) the non-toxic therapeutically acceptable salts thereof, and
- (2) as potentiating agent from about 170 to 450 milligrams of acetaminophen.
A pharmaceutical composition suitable for reducing pain in dosage unit form comprising an effective antinociceptive amount in combination of
- (1) as primary antinociceptive agent, from about 85 to 125 milligrams of a 6-methoxy-.alpha.-methyl-2-naphthalenacetic acid compound, said compound selected from (a) 6-methoxy-.alpha.-methyl-2-naphthaleneacetic acid having the formula ##STR3## and (b) the non-toxic therapeutically acceptable salts thereof, and (2) as potentiating agent, from about 170 to 450 milligrams of acetaminophen;
- wherein said primary and said potentiating agents are in admixture with a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.